Features

Our editorial board comprises a specialist group of leading industry figures who, in conjunction with the World Pharmaceutical Frontiers editorial team, identify the main drivers of the industry helping to produce regular, thought-provoking opinion pieces on the latest issues, challenges and developments.

Latest World Pharmaceuticals Feature

Safely delivering the goods: a successful supply chain
25 September, 2018
It is often the final stage of a drug’s journey that can be the...
> read more

Room for improvement: cold-chain pharmaceuticals 25 September, 2018 Huge investment and attention have been spent on improving and standardising the safe shipment of cold chain pharmaceuticals, but to what extent is there a danger of all this...

Medicine for the planet: sustainable packaging 25 September, 2018 The primary job of packaging is to ensure the safety of pharmaceutical products, but the wrong choice of material can be detrimental to a company’s sustainability goals – especially if...

Calculating risk 25 September, 2018 Last year, the International Society for Pharmaceutical Engineering released the second edition of ‘Baseline Guide: Risk-Based Manufacture of Pharmaceutical Products’, to help manage...

Packing heat: temperature control during storage and distribution 25 September, 2018 Uncontrolled temperature fluctuation during distribution and storage can be a significant source of revenue loss, and pharmaceutical companies are increasingly looking for new ways...

Keep on track and trace: benefit of traceability in the supply chain 25 September, 2018 With regulatory requirements evolving fast, much of the discussion around track and trace revolves around meeting compliance deadlines. However, there is a strong business case for...

Getting ready for serialisation: 'track and trace' solutions 25 September, 2018 EU and US deadlines for serialisation, and track and trace are fast approaching, but many pharmaceutical companies remain dangerously unprepared. With time running out, Patrick...

Combinational pride: the complexity of mixing drugs, devices and biologics 25 September, 2018 As combination products become more prevalent, they pose a number of regulatory challenges. Essentially, it isn’t always clear whether a product should be regulated as a drug, biologic...

A winning combination: digital solutions for medical treatments 25 September, 2018 The market for combination products is rapidly expanding, in part due to advances in digital health technology. World Pharmaceutical Frontiers considers the directions these...

With data in mind: best practice clinical trials management 26 July, 2018 As the outsourcing of clinical trials increases, maintaining best practice in data management when working with a contract research organisation is of the utmost importance. Grace...

Sourcing on a global scale 26 July, 2018 As more clinical trials are conducted across different regions, it is important for the industry to address the problems in the clinical supply chain that could affect the...

The legal matter: controlled substances 26 July, 2018 Working with controlled substances can pose a challenge for clinical investigators. Erica Madison looks at some of the key regulatory considerations and hears from industry leaders on...

Out in the cold chain 26 July, 2018 It is often the final stage of a drug’s journey that can be the most hazardous. Ensuring the cold chain is not broken means understanding a number of variables and options....

Rules of engagement: patient-centricity and patient management 26 July, 2018 How do we design trials to be more patient-centric and what can be done to encourage patient engagement among clinical trial teams that works for all involved? Thérèse Johnsen,...

Digital trailblazers 26 July, 2018 Industry 4.0 promises great things for the pharmaceutical sector, but reaping the rewards of this new technology comes with a number of challenges. Henk Mollee, senior director...

Check the small print: smart-labelling 26 July, 2018 Technology is transforming clinical trials, especially when it comes to packaging. The latest developments allow clinicians to fit huge amounts of information on their labels,...

Anti-cancer collaboration 26 July, 2018 Experts at The University of Texas MD Anderson Cancer Center have been talking about its innovative approach to cancer research. By connecting pharma companies with academics, rather...

Trial separation: Brexit effect on pharma 26 July, 2018 In 2019, the UK will end its membership of the EU, and with it a series of mechanisms that bind it to a continent-wide set of regulations for clinical trials. Emma Cave, a professor...

Sweet harmony: clinical trials protocol template 26 July, 2018 The increasing complexity of clinical trials, combined with the inexperience of many investigators who write the protocol templates, has long caused concerns. In 2017, US...

Silver linings:cloud-based technology for clinical trials 26 July, 2018 For pharma and biotech companies, cloud-based technology is poised to deliver simplicity and enhanced sponsor-provider relationships to the costly and prolonged clinical trials...


View all features A-Z


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.
cachename:Featurescachekey:rd-1665407042_727740091_rd-488908060_1460672566_ap1460672566_727740091_-1676441643